Meng Xu - Publications, H-index & Citations

Meng Xu

shenzhen public health service center

38H指数

133论文数

4.8K被引数

收录论文 60

发表时间

Patterns and Clinical Efficacy of Biologics Switching in Patients With Severe Asthma: A Systematic Review and Meta-Analysis 生物制剂转换在重症哮喘患者中的模式与临床疗效：一项系统评价和荟萃分析

Allergy

IF12

2026-04-04

PREAI

Yang Zheng; Ya-chun Li; Sheng-jie Li; Meng Xu; Jia-qian Hu; Wen-qu Tian; Shi-wei Chen; Xue-hui Li; Ying He; Gan Lu; Mübeccel Akdis; Ioana Agache; Cezmi Akdis; Ya-dong Gao

Evaluation of the therapeutic efficacy of precise microwave ablation combined with spinal tumor separation surgery for managing spinal metastases 评估精确微波消融联合脊柱肿瘤分离手术管理脊柱转移瘤的疗效

BMC Musculoskeletal Disorders

IF2.4

2026-02-23

PREAI

Zhao, Ziyi; Guo, Zixuan; Zhu, Qingyan; Li, Jianxiong; Xu, Meng

Exosomes derived from AHR-overexpressing human umbilical cord mesenchymal stem cells attenuate H/R injury via AHR/NLRP3 pathway AHR过表达的人脐带间充质干细胞来源的细胞外囊泡通过AHR/NLRP3通路减轻H/R损伤

Cell Cycle

IF3.4

2026-02-11

OAAI

Ying Qin; Dongyan Shen; Kequan Guo; Xu Meng; Xiaozheng Cui; Yongchao Li; Yixin Jia

Lipoprotein(a) is associated with ASCVD in individuals with non-diabetes, prediabetes, or diabetes independent of CRP

diabetes, obesity and metabolism

IF0

2026-01-21

PREAI

Zenglei Zhang PhD; Lin Zhao PhD; Zeyu Wang MD; Xianliang Zhou PhD; Xianlun Li PhD; Weixian Yang PhD; Xu Meng PhD

Effects of grape seed proanthocyanidin extract on cholesterol metabolism and antioxidant status in finishing pigs

SCIENTIFIC REPORTS

IF3.9

2024-09-10

OAAI

Wang, Wenjing; Xu, Meng; Diao, Hui; Long, Qingtao; Gan, Fang; Mao, Yi

Mechanistic study of Huangqi Guizhi Wuwu decoction amelioration of doxorubicin-induced cardiotoxicity by reducing oxidative stress and inhibiting cellular pyroptosis

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2024-06-01

OAAI

Chen, Yu; Xu, Meng; Liu, Xiao-Mei; Wang, Jian-Xin; Sun, Meng-Fan; Song, Ji-Xian; Guan, Peng; Ji, En-Sheng; Wang, Na

Circular RNA CircSATB2 facilitates osteosarcoma progression through regulating the miR-661/FUS-mediated mRNA of ZNFX1

CELLULAR SIGNALLING

IF3.7

2024-02-01

PREAI

Wang, Zhen; She, Diankun; Liu, Lei; Hua, Xianming; Zhu, Hao; Yu, Lingfeng; Wang, Han; Zhu, Yan; Fan, Gentao; Wang, Yicun; Xu, Meng; Zhou, Guangxin

Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell 微生物代谢产物丁酸通过调节细胞毒性CD8 T细胞的T细胞受体信号促进anti-PD-1抗肿瘤功效

GUT MICROBES

IF11

2023-08-27

OAAI

Zhu, Xinhai; Li, Ke; Liu, Guichao; Wu, Ruan; Zhang, Yan; Wang, Siying; Xu, Meng; Lu, Ligong; Li, Peng

Heat shock factor 1 (HSF1) specifically potentiates c-MYC-mediated transcription independently of the canonical heat shock response

CELL REPORTS

IF6.9

2023-06-01

OAAI

Xu, Meng; Lin, Ling; Ram, Babul Moni; Shriwas, Omprakash; Chuang, Kun-Han; Dai, Siyuan; Su, Kuo-Hui; Tang, Zijian; Dai, Chengkai

Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression

GUT MICROBES

IF11

2023-04-05

OAAI

Li, Yan; Hu, Yichen; Zhan, Xiang; Song, Ying; Xu, Meng; Wang, Shijie; Huang, Xiaochang; Xu, Zhenjiang Zech

FGFR inhibitors combined with nab-paclitaxel - A promising strategy to treat non-small cell lung cancer and overcome resistance

FRONTIERS IN ONCOLOGY

IF3.3

2023-02-10

OAAI

Ma, Feng; Zhu, Xinhai; Niu, Yuchun; Nai, Aitao; Bashir, Shoaib; Xiong, Yan; Dong, Yunlong; Li, Yin; Song, Jian; Xu, Meng

AHNAK2 is a biomarker and a potential therapeutic target of adenocarcinomas

ACTA BIOCHIMICA ET BIOPHYSICA SINICA

IF3.4

2022-08-19

OAAI

Xu, Meng; Cheng, Anyi; Yu, Liya; Wei, Wei; Li, Jinpeng; Cai, Cheguo

A monoclonal antibody against basic fibroblast growth factor attenuates cisplatin resistance in lung cancer by suppressing the epithelial-mesenchymal transition

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

IF2.6

2022-06-01

OAAI

Hu, Penghui; So, Kaman; Chen, Hongjie; Lin, Qimou; Xu, Meng; Lin, Yiguang

Development and Validation of a 7-Gene Inflammatory Signature Forecasts Prognosis and Diverse Immune Landscape in Lung Adenocarcinoma

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2022-03-15

OAAI

Nai, Aitao; Ma, Feng; He, Zirui; Zeng, Shuwen; Bashir, Shoaib; Song, Jian; Xu, Meng

Cell Division Cycle-Associated Genes Are Potential Immune Regulators in Nasopharyngeal Carcinoma 细胞分裂周期相关基因是鼻咽癌潜在的免疫调节因子

FRONTIERS IN ONCOLOGY

IF3.3

2022-02-14

OAAI

Jiang, Danxian; Li, Yin; Cao, Jinxin; Sheng, Lianghe; Zhu, Xinhai; Xu, Meng

Effects of dietary grape seed proanthocyanidin extract supplementation on meat quality, muscle fiber characteristics and antioxidant capacity of finishing pigs 葡萄籽原花青素对育肥猪肌肉品质、肌纤维特性及抗氧化能力的影响

FOOD CHEMISTRY

IF9.8

2022-01-01

PREAI

Xu, Meng; Chen, Xiaoling; Huang, Zhiqing; Chen, Daiwen; Li, Mingzhou; He, Jun; Chen, Hong; Zheng, Ping; Yu, Jie; Luo, Yuheng; Yu, Bing

Anti-Neuroinflammatory Effects of a Semi-Synthetic Isoorientin-Based Glycogen Synthase Kinase-3β Inhibitor in Lipopolysaccharide-Activated Microglial Cells

ACS CHEMICAL NEUROSCIENCE

IF3.9

2021-12-16

PREAI

Xu, Meng; Lantz, Megan J.; Nichols, Robert A.; Li, Qing X.

Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer

EMBO MOLECULAR MEDICINE

IF8.3

2021-12-13

OAAI

Zhou, Qian; Liang, Jinxia; Yang, Tong; Liu, Jin; Li, Bo; Li, Yingchang; Fan, Zhenzhen; Wang, Weida; Chen, Wensheng; Yuan, Sujing; Xu, Meng; Xu, Qigui; Luan, Zhidong; Xia, Zhongjun; Zhou, Penghui; Huang, Yadong; Chen, Liang

SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation (vol 12, 4664, 2021)

NATURE COMMUNICATIONS

IF15.7

2021-08-31

OAAI

Pan, Pan; Shen, Miaomiao; Yu, Zhenyang; Ge, Weiwei; Chen, Keli; Tian, Mingfu; Xiao, Feng; Wang, Zhenwei; Wang, Jun; Jia, Yaling; Wang, Wenbiao; Wan, Pin; Zhang, Jing; Chen, Weijie; Lei, Zhiwei; Chen, Xin; Luo, Zhen; Zhang, Qiwei; Xu, Meng; Li, Geng; Li, Yongkui; Wu, Jianguo

SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation SARS-CoV-2 N蛋白促进NLRP3炎性体激活诱导过度炎症

NATURE COMMUNICATIONS

IF15.7

2021-08-02

343

OAAI

研究方向